Curcumin derivative C212 inhibits Hsp90 and eliminates both growing and quiescent leukemia cells in deep dormancy.
Bi LiuYunzhu ShenHuafang HuangKimiko Della CroceMin WuYingjuan FanYang LiuJianhua XuGuang YaoPublished in: Cell communication and signaling : CCS (2020)
C212 effectively eliminates both growing and quiescent leukemia cells by inhibiting Hsp90. The property of C212 to kill quiescent leukemia cells in deep dormancy avoids the risk associated with awaking therapy-resistant subpopulation of quiescent leukemia cells during treatments, which may lead to the development of novel therapies against leukemia relapse. Video abstract.